ClinicalTrials.gg
RecruitingNCT02851043Updated Oct 13, 2026

Non-Invasive Respiratory Monitor

An interventional study of pneuRIP (breathing with resistance) and Respitrace system (Carefusion) (breathing without resistance) in Neuromuscular Diseases and Healthy Volunteers, sponsored by Nemours Children's Clinic. Recruiting at 1 site in United States. Open to participants aged 11 Years to 17 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-13.

Sponsored by Nemours Children's Clinic · Not applicable, Interventional, and Diagnostic

How we know

From the registry’s dates

  • Registered 1 year 11 months after the study started (first participant enrolled Aug 2014, registered Jul 2016).
  • Started Aug 2014; still recruiting 12 years 3 months later.
Updated Oct 13, 2026Primary completion movedStudy completion movedGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Non-randomized
Ages
11 Years to 17 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 120 studies in Neuromuscular Diseases with a site in United States — 29 open to participants now, 39 under way, 4 of them phase 3. Neuromuscular Diseases · United States.

Planned enrollment
53rd of 72
20 · median 48
Started
2014
with 4 others
No phase
23 of 120
5 open now
Primary completion
2027-12
later than 21 of 38 live
Registered
44th of 120
by date

Among the 120 studies in Neuromuscular Diseases with a site in United States, this one is the 53rd largest by planned enrollment of the 72 interventional ones that give a count, is one of 5 that started in 2014, is one of 23 with no phase, reaches primary completion later than 21 of the 38 other live ones, and was the 44th registered.

Neuromuscular Diseases

361 studies on the registry are indexed under Neuromuscular Diseases; 96 are open to participants now.

Browse Neuromuscular Diseases studies →

Open to participants now

29 of the 120 studies in Neuromuscular Diseases with a site in United States are open now. Recruiting first, the newest first:

24 more — sign in →

All 29 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 69 Neuromuscular Diseases studies recruiting now, 39 (57%) set no upper age limit and 22 (32%) stop at 75 or younger; 35 take children under 18; 16 take healthy volunteers.

This study: 11 Years to 17 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 120 studies in Neuromuscular Diseases with a site in United States, or all of them as a file.
02

Study summary

This study will clinically evaluate a newly developed respiratory monitor - pneuRIP. The pneuRIP uses Respiratory Inductance Plethysmography (RIP) bands to measure key breathing indices non-invasively. This study compares the pneuRIP to an existing Respitrace system (Carefusion, Yorba Linda CA). 10 normal children and 10 children with breathing difficulties will be monitored with both systems.

Read the detailed description

Firstly, ten healthy children will participate in a trial to evaluate the pneuRIP. They will be fitted with the bands around their abdomen and chest. The pneuRIP will be connected to the bands through electrodes. Breathing is then measured wirelessly with an iPad. They will be asked to lie down. They are asked to breath normally then asked to breath with a resistive elements to place in their mouth. The resistive elements makes it difficult to breath (similar to breathing through a straw). They will breathe for 3 minutes for both conditions as we record their breathing with the pneuRIP and the Respitrace. These data will be compared.

Secondly, A group of 10 subjects from the outpatient muscle clinic will be fitted with the chest and abdomen bands. The Respitrace monitor and the pneuRIP will record their breathing patterns. Data from the two systems will then be compared.

03

Conditions studied

  • Neuromuscular Diseases
  • Healthy Volunteers
04

Who can participate

Ages eligible
11 Years to 17 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Healthy volunteers
  • Neuromuscular disease subjects with mild breathing difficulty
  • Capable of following verbal instructions

Exclusion criteria

Exclusion Criteria:

  • Severe breathing difficulties
05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
20 participants (estimated)

Study arms

  • Experimental
    pneuRIP(breathing with resistance)

    Testing the subjects breathing with resistance

    Device: pneuRIP (breathing with resistance) · Device: Respitrace system (Carefusion) (breathing without resistance)

  • No intervention
    Respitrace system (Carefusion) (breathing without resistance)

    Testing subjects breathing without resistance

Interventions

  • DevicepneuRIP (breathing with resistance)

    subjects are given a resistance element to breath through

  • DeviceRespitrace system (Carefusion) (breathing without resistance)

    subjects are asked to breath normally

06

What researchers measure

Primary outcomes

  1. Breathing rate

    The breathing rate is measured by two different monitors

    Time frame: Immediately after test

Secondary outcomes

  1. Labored breathing Index

    The labored breathing index is measured by two different monitors

    Time frame: Immediately after test

  2. Phase Difference

    The phase difference between the pneuRIP and Respitrace is measured by two different monitors

    Time frame: Immediately after test

  3. Percent rib cage

    The percentage of breathing performed by the rib cage is measured by two different monitors

    Time frame: Immediately after test

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Aug 2014 (actual). Primary completion is estimated for Dec 2027, 160 months after the start.

Of 75 non-industry interventional studies with no phase under Neuromuscular Diseases, half reached primary completion within 31 months of starting (the median), counting those still running; a quarter within 18 and three quarters within 47. This study's planned 160 months is above that.

Counting every sponsor, half of 84 studies reached it within 25 months; a quarter within 12 and three quarters within 43.

Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 13, 2026: primary completion Dec 2026 → Dec 2027 and completion Dec 2026 → Dec 2027.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Jul 19, 2016
First posted
Aug 1, 2016
StartActual
Aug 2014
Primary completionEst.
Dec 2027was Dec 2026
CompletionEst.
Dec 2027was Dec 2026
Last update
Oct 13, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Primary completion
Dec 2026→Dec 2027
Oct 13, 2026
Study completion
Dec 2026→Dec 2027
Oct 13, 2026
Show all 1 update
  1. Oct 13, 2026
    Primary completion Dec 2026→Dec 2027
    Study completion Dec 2026→Dec 2027
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT02851043
Responsible party
Tariq Rahman (Principal Research Engineer, Nemours Children's Clinic) — Principal investigator
First posted
Aug 1, 2016
Start date
Aug 2014
Primary completion
Dec 2027 (estimated)
Completion
Dec 2027 (estimated)
Last update
Oct 13, 2026

Study contacts

Tariq Rahman, PhD
Contact
trahman@nemours.org
302 651 6831
Thomas Shaffer, PhD
principal investigator · Nemours

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion